Literature DB >> 6781964

Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

H J Lisch, S Sailer.   

Abstract

In order to study the lipoprotein pattern in diabetes mellitus, plasma lipoproteins were isolated by rate zonal centrifugation in 12 control subjects (median fasting blood glucose level: 80 mg/dl (range: 74-86)), 14 diabetic patients treated by diet alone 104 mg/dl (76-153), 27 patients treated by diet plus insulin (180 mg/dl (106-404)), and 32 patients treated by diet plus sulphonylurea [178 mg/dl (103-361)]. No significant differences of median relative body weight existed between the four groups. Neither the diabetic group on diet alone nor the insulin-treated group differed significantly from control subjects with respect to lipid and lipoprotein concentrations. Diabetics treated with diet plus sulphonylurea, however, differed significantly from the control group with regard to the following parameters (median and range); plasma triglycerides (210 [75-620) mg/dl; p less than 0.01)] and intermediate density lipoproteins (65 (10-338) mg/dl; p less than 0.05)) were higher; low density lipoproteins (236 (82-418) mg/dl; p less than 0.05)) and high density lipoproteins2 (HDL2) [51 (12-121) mg/dl; p less than 0.01)] concentrations were lower. When data from all 85 studied individuals were analysed together, significant positive correlations were observed between fasting blood glucose and plasma triglyceride concentration (r = 0.28, p less than 0.01), and between fasting blood glucose and plasma very low density lipoproteins (VLDL) (r = 0.23, p less than 0.05). A negative correlation was found between blood glucose and plasma HDL2 (r = -0.29, p less than 0.01). In addition, VLDL correlated negatively with HDL2 (r = -0.89, p less than 0.001) but not with plasma HDL3 concentration. It is concluded that the deranged lipoprotein metabolism in diabetes mellitus may be better controlled by insulin than by sulphonylureas.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6781964     DOI: 10.1007/BF00262013

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  An enzymatic method for the determination of the initial rate of cholesterol esterification in human plasma.

Authors:  W Patsch; S Sailer; H Braunsteiner
Journal:  J Lipid Res       Date:  1976-03       Impact factor: 5.922

3.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

4.  Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

Authors:  A L Kennedy; T R Lappin; T D Lavery; D R Hadden; J A Weaver; D A Montgomery
Journal:  Br Med J       Date:  1978-10-28

5.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

6.  Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation.

Authors:  J R Patsch; S Sailer; G Kostner; F Sandhofer; A Holasek; H Braunsteiner
Journal:  J Lipid Res       Date:  1974-07       Impact factor: 5.922

7.  [Plasma lipids in patients with diabetes mellitus].

Authors:  H Braunsteiner; S Sailer; F Sandhofer
Journal:  Klin Wochenschr       Date:  1966-02-01

8.  The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal.

Authors:  R Paisey; R S Elkeles; J Hambley; P Magill
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

9.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  [Lipid values in normal persons and patients with myocardial infarct. Statistical evaluation by means of an electronic computer].

Authors:  H Braunsteiner; S Sailer; F Sandhofer; R Di Pauli; F Gabl; A Jung
Journal:  Wien Klin Wochenschr       Date:  1965-11-05       Impact factor: 1.704

View more
  17 in total

Review 1.  Treatment of diabetes: the effect on serum lipids and lipoproteins.

Authors:  P K Merrin; R S Elkeles
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Lack of a lipoprotein-induced insulin resistance in hepatoma cells in culture.

Authors:  F Rinninger; B Wolf; H U Haering; W Bachmann
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

3.  Effects of an increased content of cereal fibre in the diet of Type 2 (non-insulin-dependent) diabetic patients.

Authors:  B Karlström; B Vessby; N G Asp; M Boberg; I B Gustafsson; H Lithell; I Werner
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

4.  Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion.

Authors:  G Sartor; D Ursing; P Nilsson-Ehle; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

Authors:  C M Barbagallo; M R Averna; S Amato; G Marino; M Labisi; A C Rao; M Barbagallo; G F Cupidi; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

Review 6.  A rational approach to drug therapy of type 2 diabetes mellitus.

Authors:  J M Chehade; A D Mooradian
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

7.  Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.

Authors:  C Breier; H J Lisch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1983-09-15

8.  Effect of treatment of the concentration of lipoproteins and the postheparin-lipolytic activity in the plasma of noninsulin-dependent diabetics.

Authors:  C Breier; H J Lisch; S Sailer
Journal:  Klin Wochenschr       Date:  1982-06-01

9.  Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.

Authors:  N al-Muhtaseb; A R al-Yuosuf; J S Bajaj
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

Review 10.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.